These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD. Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796 [TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. Gantner F; Tenor H; Gekeler V; Schudt C; Wendel A; Hatzelmann A J Allergy Clin Immunol; 1997 Oct; 100(4):527-35. PubMed ID: 9338548 [TBL] [Abstract][Full Text] [Related]
9. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385 [TBL] [Abstract][Full Text] [Related]
10. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase. Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223 [TBL] [Abstract][Full Text] [Related]
11. Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Giembycz MA; Corrigan CJ; Seybold J; Newton R; Barnes PJ Br J Pharmacol; 1996 Aug; 118(8):1945-58. PubMed ID: 8864528 [TBL] [Abstract][Full Text] [Related]
12. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Lavan BE; Lakey T; Houslay MD Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds. de Cheffoy de Courcelles D; de Loore K; Freyne E; Janssen PA J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613 [TBL] [Abstract][Full Text] [Related]
15. Differential modulation of cytokine production by drugs: implications for therapy in heart failure. Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes. Aleksijevic A; Lugnier C; Giron C; Mayer S; Stoclet JC; Lang JM Int J Immunopharmacol; 1987; 9(5):525-31. PubMed ID: 3040609 [TBL] [Abstract][Full Text] [Related]
18. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells. Souness JE; Diocee BK; Martin W; Moodie SA Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells. Whalen MM; Crews JD Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124 [TBL] [Abstract][Full Text] [Related]
20. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro. Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]